These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

893 related articles for article (PubMed ID: 17519394)

  • 21. Toxicogenomic analysis of the hepatic effects of perfluorooctanoic acid on rare minnows (Gobiocypris rarus).
    Wei Y; Liu Y; Wang J; Tao Y; Dai J
    Toxicol Appl Pharmacol; 2008 Feb; 226(3):285-97. PubMed ID: 17976672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Species-specific concentrations of perfluoroalkyl contaminants in farm and pet animals in Japan.
    Guruge KS; Manage PM; Yamanaka N; Miyazaki S; Taniyasu S; Yamashita N
    Chemosphere; 2008 Aug; 73(1 Suppl):S210-5. PubMed ID: 18439642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging endocrine disrupters: perfluoroalkylated substances.
    Jensen AA; Leffers H
    Int J Androl; 2008 Apr; 31(2):161-9. PubMed ID: 18315716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What's so special about the developing immune system?
    Burns-Naas LA; Hastings KL; Ladics GS; Makris SL; Parker GA; Holsapple MP
    Int J Toxicol; 2008; 27(2):223-54. PubMed ID: 18404545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developmental Exposures to Perfluoroalkyl Substances (PFASs): An Update of Associated Health Outcomes.
    Liew Z; Goudarzi H; Oulhote Y
    Curr Environ Health Rep; 2018 Mar; 5(1):1-19. PubMed ID: 29556975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pipping success and liver mRNA expression in chicken embryos exposed in ovo to C8 and C11 perfluorinated carboxylic acids and C10 perfluorinated sulfonate.
    O'Brien JM; Crump D; Mundy LJ; Chu S; McLaren KK; Vongphachan V; Letcher RJ; Kennedy SW
    Toxicol Lett; 2009 Oct; 190(2):134-9. PubMed ID: 19595750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overview of developmental and reproductive toxicity research in China: history, funding mechanisms, and frontiers of the research.
    Wu C
    Birth Defects Res B Dev Reprod Toxicol; 2010 Feb; 89(1):9-17. PubMed ID: 20135688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse effects of perfluoroalkyl acids on fish and other aquatic organisms: A review.
    Lee JW; Choi K; Park K; Seong C; Yu SD; Kim P
    Sci Total Environ; 2020 Mar; 707():135334. PubMed ID: 31874399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic effects of perfluoroalkyl acids mixtures with J-shaped concentration-responses on viability of a human liver cell line.
    Hu J; Li J; Wang J; Zhang A; Dai J
    Chemosphere; 2014 Feb; 96():81-8. PubMed ID: 23942018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in hepato-renal gene expression in microminipigs following a single exposure to a mixture of perfluoroalkyl acids.
    Sakuma A; Wasada Ochi H; Yoshioka M; Yamanaka N; Ikezawa M; Guruge KS
    PLoS One; 2019; 14(1):e0210110. PubMed ID: 30608957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hazard assessment of fluorinated alternatives to long-chain perfluoroalkyl acids (PFAAs) and their precursors: status quo, ongoing challenges and possible solutions.
    Wang Z; Cousins IT; Scheringer M; Hungerbuehler K
    Environ Int; 2015 Feb; 75():172-9. PubMed ID: 25461427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxicological mechanisms of emerging per-/poly-fluoroalkyl substances: Focusing on transcriptional activity and gene expression disruption.
    Chen L; Xie Y; Li M; Mortimer M; Li F; Guo LH
    Toxicology; 2023 Aug; 494():153566. PubMed ID: 37263573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Global warming potentials of Hydrofluoroethers.
    Blowers P; Moline DM; Tetrault KF; Wheeler RR; Tuchawena SL
    Environ Sci Technol; 2008 Feb; 42(4):1301-7. PubMed ID: 18351109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential use of human tissues for toxicity research and testing.
    Frazier JM; Tyson CA; McCarthy C; McCormick JJ; Meyer D; Powis G; Ducat L
    Toxicol Appl Pharmacol; 1989 Mar; 97(3):387-97. PubMed ID: 2609338
    [No Abstract]   [Full Text] [Related]  

  • 36. Wildlife toxicology.
    Kamienski FX
    Environ Sci Technol; 1983 Feb; 17(2):62A. PubMed ID: 22656350
    [No Abstract]   [Full Text] [Related]  

  • 37. Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origins.
    Buck RC; Franklin J; Berger U; Conder JM; Cousins IT; de Voogt P; Jensen AA; Kannan K; Mabury SA; van Leeuwen SP
    Integr Environ Assess Manag; 2011 Oct; 7(4):513-41. PubMed ID: 21793199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers.
    Olsen GW; Burris JM; Ehresman DJ; Froehlich JW; Seacat AM; Butenhoff JL; Zobel LR
    Environ Health Perspect; 2007 Sep; 115(9):1298-305. PubMed ID: 17805419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polyfluorinated compounds: past, present, and future.
    Lindstrom AB; Strynar MJ; Libelo EL
    Environ Sci Technol; 2011 Oct; 45(19):7954-61. PubMed ID: 21866930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA).
    Steenland K; Fletcher T; Savitz DA
    Environ Health Perspect; 2010 Aug; 118(8):1100-8. PubMed ID: 20423814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.